These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 10896881

  • 1. Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans.
    Gutzwiller JP, Drewe J, Ketterer S, Hildebrand P, Krautheim A, Beglinger C.
    Am J Physiol Regul Integr Comp Physiol; 2000 Jul; 279(1):R189-95. PubMed ID: 10896881
    [Abstract] [Full Text] [Related]

  • 2. Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans.
    Beglinger C, Degen L, Matzinger D, D'Amato M, Drewe J.
    Am J Physiol Regul Integr Comp Physiol; 2001 Apr; 280(4):R1149-54. PubMed ID: 11247838
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans.
    Matzinger D, Gutzwiller JP, Drewe J, Orban A, Engel R, D'Amato M, Rovati L, Beglinger C.
    Am J Physiol; 1999 Dec; 277(6):R1718-24. PubMed ID: 10600919
    [Abstract] [Full Text] [Related]

  • 4. Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women.
    Lieverse RJ, Masclee AA, Jansen JB, Rovati LC, Lamers CB.
    Biol Psychiatry; 1995 Mar 01; 37(5):331-5. PubMed ID: 7748985
    [Abstract] [Full Text] [Related]

  • 5. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB.
    Gut; 1994 Apr 01; 35(4):501-5. PubMed ID: 8174988
    [Abstract] [Full Text] [Related]

  • 6. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans.
    Matzinger D, Degen L, Drewe J, Meuli J, Duebendorfer R, Ruckstuhl N, D'Amato M, Rovati L, Beglinger C.
    Gut; 2000 May 01; 46(5):688-693. PubMed ID: 10764713
    [Abstract] [Full Text] [Related]

  • 7. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans.
    Drewe J, Gadient A, Rovati LC, Beglinger C.
    Gastroenterology; 1992 May 01; 102(5):1654-9. PubMed ID: 1568575
    [Abstract] [Full Text] [Related]

  • 8. The effects of loxiglumide on food intake in normal weight volunteers.
    French SJ, Bergin A, Sepple CP, Read NW, Rovati L.
    Int J Obes Relat Metab Disord; 1994 Nov 01; 18(11):738-41. PubMed ID: 7866473
    [Abstract] [Full Text] [Related]

  • 9. Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion.
    Greenough A, Cole G, Lewis J, Lockton A, Blundell J.
    Physiol Behav; 1998 Nov 15; 65(2):303-10. PubMed ID: 9855480
    [Abstract] [Full Text] [Related]

  • 10. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man.
    Muurahainen N, Kissileff HR, Derogatis AJ, Pi-Sunyer FX.
    Physiol Behav; 1988 Nov 15; 44(4-5):645-9. PubMed ID: 3237850
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats.
    Meereis-Schwanke K, Klonowski-Stumpe H, Herberg L, Niederau C.
    Peptides; 1998 Nov 15; 19(2):291-9. PubMed ID: 9493861
    [Abstract] [Full Text] [Related]

  • 12. Bombesin reduces food intake after a preload in man by a cholecystokinin-independent mechanism.
    Lieverse RJ, Jansen JB, Masclee AA, Lamers CB.
    Clin Sci (Lond); 1993 Sep 15; 85(3):277-80. PubMed ID: 8403798
    [Abstract] [Full Text] [Related]

  • 13. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A, Kulesza E, Konturek SJ.
    Scand J Gastroenterol; 1990 Jul 15; 25(7):731-8. PubMed ID: 2396088
    [Abstract] [Full Text] [Related]

  • 14. Effect of gastric distension prior to eating on food intake and feelings of satiety in humans.
    Oesch S, Rüegg C, Fischer B, Degen L, Beglinger C.
    Physiol Behav; 2006 May 30; 87(5):903-10. PubMed ID: 16549077
    [Abstract] [Full Text] [Related]

  • 15. Satiety effects of cholecystokinin in humans.
    Lieverse RJ, Jansen JB, Masclee AM, Lamers CB.
    Gastroenterology; 1994 Jun 30; 106(6):1451-4. PubMed ID: 8194689
    [Abstract] [Full Text] [Related]

  • 16. Elevation of feed intake in parasite-infected lambs by central administration of a cholecystokinin receptor antagonist.
    Dynes RA, Poppi DP, Barrell GK, Sykes AR.
    Br J Nutr; 1998 Jan 30; 79(1):47-54. PubMed ID: 9505802
    [Abstract] [Full Text] [Related]

  • 17. Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism.
    Lieverse RJ, Jansen JB, van de Zwan A, Samson L, Masclee AA, Rovati LC, Lamers CB.
    J Clin Endocrinol Metab; 1993 Jun 30; 76(6):1495-8. PubMed ID: 8501156
    [Abstract] [Full Text] [Related]

  • 18. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
    Hayes MR, Savastano DM, Covasa M.
    Physiol Behav; 2004 Sep 30; 82(4):663-9. PubMed ID: 15327914
    [Abstract] [Full Text] [Related]

  • 19. Effects of a specific CCK-A antagonist, Loxiglumide, on postprandial mood and sleepiness.
    Wells AS, Read NW, Fried M, Borovicka J, D'Amato M.
    J Psychopharmacol; 1997 Sep 30; 11(3):241-6. PubMed ID: 9305416
    [Abstract] [Full Text] [Related]

  • 20. Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men.
    Gutzwiller JP, Degen L, Matzinger D, Prestin S, Beglinger C.
    Am J Physiol Regul Integr Comp Physiol; 2004 Sep 30; 287(3):R562-7. PubMed ID: 15105167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.